Navigation Links
The Acute Liver Failure Study Group Initiates Phase 2a Study of OCR-002 for Treatment of Acute Liver Failure after Acetaminophen Overdose
Date:11/8/2012

SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Ocera Therapeutics, Inc. announced that the first patient has enrolled in a Phase 2a study to evaluate the safety and tolerability of OCR-002 (ornithine phenylacetate) in the treatment of patients with acute liver injury (ALI) as well as those that have progressed to acute liver failure (ALF) following acetaminophen overdose.

OCR-002 is an investigational drug designed to directly reduce circulating blood levels of ammonia which, at high levels, is neurotoxic, associated with brain injury, and may lead to hepatic encephalopathy and mortality. The investigator-sponsored study, referred to as STOP-ALF, is being conducted by The Acute Liver Failure Study Group, a National Institutes of Health-funded consortium led by UT Southwestern Medical Center.

"When a patient presents with acute liver failure, physicians have no medicines available that can directly lower circulating levels of ammonia, which drive hepatic encephalopathy and can lead to coma and death," stated William M. Lee, M.D., Lead Investigator, and Professor, Internal Medicine, UT Southwestern.  "OCR-002 acts specifically by scavenging for and removing ammonia from the blood, which may prevent the development of hepatic encephalopathy in patients at risk. Our collaboration to study OCR-002 is a key step towards understanding more about a potentially lifesaving drug."

The STOP-ALF study is a Phase 2a multi-center, open-label study that will enroll 24 participants with severe acute liver injury or acute liver failure. The primary endpoint will be safety and tolerability. Secondary endpoints include measurement of OCR-002 plasma concentration, change in venous ammonia and neurological function.

Hepatic encephalopathy is an often-reversible neuropsychiatric abnormality observed in patients with acute liver failure; it is marked by a worsening of brain function when the liver is no longer able to remove toxic substances such as ammo
'/>"/>

SOURCE Ocera Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
2. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
3. Significant Pre-Clinical Data in Acute Lung Injury
4. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
5. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
6. Vibra Healthcare Announces Agreement To Manage Two Acute Rehabilitation Hospitals
7. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
8. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
9. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
10. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
11. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 Patient engagement has become a ... are turning to an assortment of marketing activities ... of this evolving approach to patient engagement, marketers ... engage patients throughout their experiences with a disease ... mapping the patient journey and employing a consumer ...
(Date:7/11/2014)... According to a new ... Material, Application (Healthcare, Homeland security, Industrial application, Nuclear ... Hand-Held Instruments, Fixed, and Installed Instruments) & Geography ... by MarketsandMarkets, the Scintillator Market is expected to ... to 2020, and reach $479.16 Million in 2020. ...
(Date:7/11/2014)... July 11, 2014 On ... down 0.52%, the Dow Jones Industrial Average finished the day ... 1,964.68, down 0.41%. The losses were broad based as eight ... S&P 500 Health Care Sector Index ended the day at ... the last one month. Investor-Edge has initiated coverage on the ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
(Date:7/11/2014)... Rochester, NY (PRWEB) July 11, 2014 ... Surgery ’s own, Dr. William Koenig, has topped a ... his peers, he has performed over 400 successful procedures ... , Dr. Koenig is well known across the country ... His exceptional safety record has long been the foundation ...
(Date:7/11/2014)... Ticket Down is a reliable source ... When it comes to the summer concert schedule, it just ... native is one of the biggest names in country music and ... currently out on his “That’s My Kind of Night” tour featuring ... will be making through the rest of the summer and into ...
(Date:7/11/2014)... July 11, 2014 Biostimulants are widely ... in turf and ornamentals. These also help turf and ... length of roots. Turf, ornamentals, and flowers appear healthy ... this usage has increased from the last few years. ... and ornamentals is Europe, with around 40% share in ...
(Date:7/11/2014)... of its kind has found that organic foods ... their conventional counterparts, including more antioxidants and fewer, ... at an unprecedented 343 peer-reviewed publications comparing the ... plant-based foods, including fruits, vegetables, and grains. The ... differences between organic and non-organic foods. , ...
(Date:7/11/2014)... July 11, 2014 Ticket Down is a reliable ... in Mountain View, CA. Over the years Luke Bryan has ... Not only does he do well at award shows, but each ... the most anticipated tours of the genre and this summer is ... artists can compare to the popularity and success that is currently ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3
... County Washington First in Nation to Embrace the Vending Industry,s ... ... April 16 The nation,s vending industry will,unveil tomorrow a ... Automatic Merchandising Association (NAMA),President Richard M. Geerdes, NCE announced today. ...
... & Science University researchers have identified a gene that ... finding is important because expression of this gene is ... breast cancers, said Charles Lopez, M.D., Ph.D., OHSU Cancer ... will be presented at a minisymposium on Wednesday April ...
... Industry supports hundreds of programs helping millions in ... WASHINGTON, April 16 The worldwide,pharmaceutical industry ... research-based biopharmaceutical companies, global,health leaders and policymakers together ... the developing world., Serving as a convening ...
... the,leading provider of scientifically proven brain fitness programs, announced,today ... MIT,s,AgeLab, has joined its advisory board. Dr. Coughlin was ... the 12 people who will most affect your,retirement. He ... people,improve performance in driving, health and mobility., The ...
... is a growing concern for pediatricians and caregivers. In ... created guidelines for children regarding physical activity and screen time, ... The AAP has made the following recommendations: 1) boys ... should take at least 13,000 steps a day; and 3) ...
... Investment Partners, L.P.,("Brandes") announces that, on April 8th, ... "Company"), a pharmaceutical manufacturer,based in Japan and listed ... to be submitted for shareholder approval at the ... its investment,advisory clients, Brandes currently holds in excess ...
Cached Medicine News:Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 2Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 3Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 4Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3Health News:AgeLab Director Brings Wisdom to Aging Brains 2Health News:Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting 2Health News:Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting 3Health News:Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting 4
Each blade is perfectly crafted to enhance your performance, expertise and safety. You are always assured of a uniform cutting edge and a perfect fit on scalpel handles with every procedure....
... 6-inch Electro-Dermatome. This is the only ... six inch graft can cover most adult ... seams. This dermatome has been designed to ... is decreased considerably and the handle temperature ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Medicine Products: